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in vitamin D group whereas in placebo group decreased Medial-JSW
and increased Osteophyte was observed in Tt and tt genotype in com-
parion to TT genotype of TaqI polymorphism. These changes were of
borderline signiﬁcance. No similar effect was observed for ApaI
polymorphism.
Conclusions: VDR gene polymorphism (TaqI) inﬂuences the clinico-
radiological response to vitamin D supplementation in Osteoarthritis
knee with insufﬁcient 25-OHD levels. If these results are conﬁrmed by
the larger studies, this would justify tailoring vitamin D supplementa-
tion using VDR genotyping in vitamin D insufﬁcient KOA patients.
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TOWARDS A MOLECULAR DESCRIPTION OF DISEASE; A SYSTEMS
BIOLOGY APPROACH IN OSTEOARTHRITIS
L. Labusca y, U. Greiser z, F. Zugun Eloae x, K. Mashayekhi k. yUniv. Hosp.
Saint Spiridon, Iasi, Romania; zNetwork of Excellence for Functional
Biomaterials NFB Galway Ireland, Galway, Ireland; xDept. of Molecular
Genetics and Immunology “Gr.T.Popa: Univ. of Med. and Pharmacy Iasi
Romania, Iasi, Romania; k SBIM Systems Bioinformatics and Modeling
GmbH, Frankfurt, Germany, Frankfurt, Germany
Purpose: Osteoarthritis represents an increasing threat worldwide,
affects people of all ages, inducing premature disability and economic
impairment. Bioinformatics, computational and systems biology are
used for deﬁning molecular proﬁle of diseases by integrating available
information. This approach requires knowledge about details as well as
overview about predictable interconnections. Bioinformatics is pro-
posed as a tool in organizing existent knowledge aiming introduction of
the discovery science principles in handling clinical and experimental
data. Computational biology is used to detect possible correlations and
links in molecular pathways and further pointed as one useful method
to design focused systematic research.
Methods: Genes and proteins involved in the process speciﬁc to Homo
sapiens have been extracted using data available in Gene Cards, Uniprot,
pubmed cited literature and gene ontology (GO) databases. Interactions
network analysis was build using Gene Regulatory Network (GRN) and
Gene Set Enrichment Analysis (GSEA) considering the following factors;
down and up regulation, co expression, predicted protein interaction,
Transcription Factor (TF) regulation. ChIP-seq data sets were aligned
usin to build version version hg19 of the human genome. Enhancers
were deﬁned as regions of ChIP-seq enrichment for H3K27ac in human
cells.
Results: Several sets of genes previously associated with chondrocyte
metabolism and inﬂamation were identiﬁed. Gene expression not
previously associated with OA have been identiﬁed. OA-associated SNPs
appear in super-enhancers of chondroprogenitor cells.
Conclusion: systems biology approach in disease characterization has
the potential in deﬁning the pathological mechanisms, in offering bio-
marker and therapeutical targets. Our approach is acontribution in this
respect towards a deﬁnition of osteoarthritis.
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IMPROVED PREDICTION OF KNEE OSTEOARTHRITIS PROGRESSION
BY GENETIC POLYMORPHISMS. ARTHROTEST STUDY RESULTS
F.J. Blanco y, I. M€oller z, Arthrotest Study Group, N. Bartolome x,
M. Artieda x, D. Tejedor x, A. Martínez x, E. Montell k, H. Martínez k,
M. Herrero k, J. Verges k. y INIBIC-Hosp. Univ.rio A Coru~na, A Coru~na,
Spain; z Inst. Poal de Reumatología, Barcelona, Spain; x Progenika
Biopharma, S.A., Bilbao, Spain; kBioiberica S.A., Barcelona, Spain
Purpose: Single Nucleotide Polymorphisms (SNPs) are inherited
genetic variations that can predispose or protect individuals against
clinical events. Osteoarthritis (OA) has a multifactorial etiology with a
strong genetic component. Genetic factors inﬂuence not only knee OA
onset, but also disease progression. The aim of this study was to develop
a genetic prognostic tool to predict radiologic progression towards
severe disease in primary knee OA (KOA) patients.
Methods: Cross-sectional, retrospective, multicentric, association study
with Spanish KOA patients. 595 patients from 31 sites were selected.
Inclusion criteria: Caucasian patients aged 40 years at the time of
diagnosis of primary KOA, for whom two anteroposterior X-rays were
available, one corresponding to the time of OA diagnosis with Kellgren–
Lawrence grade 2 or 3 and the other to the end of the follow-up period.Patients who progressed to KL score 4 or were referred for total knee
replacement in  8 years since the diagnosis were classiﬁed as pro-
gressors to severe disease. A unique expert viewer measured the radi-
ologic progression from all X-rays. A candidate gene study analyzing
774 SNPs was conducted. SNP genotyping was performed with Illumina
Golden gate technology or KASPar chemistry. Clinical variables of the
initial stages of the disease (gender, BMI, age at diagnosis, OA in the
contralateral knee and OA in other joints) were registered as potential
predictors. Univariate analysis was done to identify associations
between the baseline clinical variables or SNPs and KOA progression.
SNPs and clinical variables with an association of p < 0.05 were inclu-
ded on the multivariate analysis using forward logistic regression.
Results: 282 patients fulﬁlled DNA and X-ray quality control criteria
(220 in the exploratory cohort and 62 in the validation cohort). The
univariate association analysis showed that one of the clinical variables
and 23 SNPs were signiﬁcantly associated to KOA severe progression in
the exploratory cohort (p < 0.05). The predictive accuracy of the clinical
variable was limited, as indicated by the area under the ROC curve (AUC
¼ 0.66). When genetic variables were added to the clinical model (full
model) the prediction of KOA progression was improved and the AUC
increased to 0.82. Combining only genetic variables, a predictive model
with a good accuracy (AUC ¼ 0.78) was also obtained. The predictive
ability for KOA progression of the full model was conﬁrmed on the
validation cohort (two-sample Z-test p ¼ 0.190).
Conclusions: Genetic polymorphisms predict radiologic progression
more accurately than clinical variables. An accurate prognostic tool to
predict primary KOA progression has been developed, based on genetic
and clinical information from OA patients. This model could help
clinicians optimize patients’ preventive and therapeutic care, according
to their OA progression rate, and personalize disease management.
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FUNCTIONAL ANALYSIS OF THE OSTEOARTHRITIS SUSCEPTIBILITY
LOCUS MARKED BY THE POLYMORPHISM rs10492367
K. Johnson, L.N. Reynard, J. Loughlin. Newcastle Univ., Newcastle upon
Tyne, United Kingdom
Purpose: The arcOGEN genome-wide association study, published in
2012, reported that the rs10492367 G to T single nucleotide poly-
morphism (SNP) marks a region on chromosome 12p that is associated
with hip osteoarthritis (OA) in Europeans, with an odds ratio (OR) of
1.14 and a p-value of 1.48  108. rs10492367 is an intergenic SNP
located 59 kb downstream of kelch domain-containing protein 5
(KLHDC5) and 96 kb downstream of parathyroid hormone-like hor-
mone (PTHLH). While there is sparse published data for KLHDC5,
PTHLH has been widely studied, with its protein having a crucial role in
endochondral ossiﬁcation. As rs10492367 is not in high linkage dis-
equilibrium (LD) with any common non-synonymous transcript poly-
morphisms, it is unlikely that the OA association is due to a change in
the coding sequence of either of these two nearby genes. Instead,
rs10492367 could function as a cis-acting polymorphism, inﬂuencing
PTHLH or KLHDC5 gene transcription, resulting in allelic expression
imbalance (AEI). Furthermore, as rs10492367 resides in a region pre-
dicted to have enhancer activity based on the ENCODE dataset, identi-
ﬁcation of functional variants within this region that affect such activity
will prove vital in dissecting the OA signal. Thus, the aims of this study
are to assess whether rs10492367 marks AEI in either PTHLH or
KLHDC5, and to determine if any intergenic SNPs in high LD (0.8) with
rs10492367 are functionally active in regulating enhancer activity of
this OA associated region.
Methods: Cartilage was obtained from the hip or knee of OA patients
who had undergone elective total joint replacement, and from non-OA
patients who had undergone total joint replacement as a result of a
neck-of-femur fracture (NOF). Using quantitative real-time polymerase
chain reaction (qPCR), overall expression of PTHLH and KLHDC5 was
measured in cDNA synthesised from cartilage RNA and stratiﬁed by
rs10492367 genotype. Allelic expression imbalance analysis was per-
formed using pyrosequencing. Since rs10492367 is intergenic, the
transcript SNPs rs6253 in PTHLH and rs9029 in KLHDC5 were used as
markers to measure allelic imbalance in 29 and 21 heterozygous OA
patients, respectively. The data was stratiﬁed by rs10492367 genotype
to evaluate whether any allelic differences corresponded to the pres-
ence of either of the association SNP alleles. Eight SNPs were in an LD of
0.8 with the association SNP; thus, 18 pGL3 promoter vector con-
structs were generated, each of which contained one of the alleles from
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presence of any of the alleles inﬂuenced the enhancer activity of the
constructs in the U2OS osteosarcoma cell line, which expresses both
genes.
Results: There was a signiﬁcant increase in PTHLH expression in OA
females relative to NOF females (p ¼ 0.02), however there was no evi-
dence for any signiﬁcant correlation between PTHLH expression and
rs10492367 genotype in OA cartilage. Similarly, there was no correla-
tion between KLHDC5 expression and rs10492367 genotype. In addi-
tion, although allelic imbalance was observed, it did not correlate with
the OA association SNP genotype. In the U2OS cell line luciferase assays,
the OA associated alleles of the intergenic SNPs rs11049206 and
rs58649696 resulted in signiﬁcantly reduced enhancer activities rela-
tive to the non-OA alleles (p ¼ 0.0025 and p > 0.0001, respectively).
Conclusions: In OA cartilage, our data does not support an association
of rs10492367 with OA by mediating its effect on PTHLH or KLHDC5
expression. This may be due to the current analysis being limited to the
aforementioned genes in end stage OA cartilage, as the OA associated
regionmay be exerting its effects on other genes, in other tissue types or
at different stages of development. However, luciferase reporter assays
in an osteosarcoma cell line identiﬁed two intergenic SNPs in high LD
with the associated SNP rs10492367 that independently resulted in
reduced enhancer activity when the OA associated alleles were present.
This current research therefore highlights the functional activity of the
OA associated region marked by rs10492367.
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ADIPOSE TISSUE ASSOCIATED GENES IN HAND OSTEOARTHRITIS IN
FINNISH WOMEN
S. H€am€al€ainen, S. Solovieva, T. Vehmas, P. Leino-Arjas, A. Hirvonen.
Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Osteoarthritis (OA) is the most common joint disorder, the
joints of the hand being the most frequent site affected. Available evi-
dence suggests that genetic factors may play a major role in the etiology
of OA.We chose to analyze in our hand OAmaterial 21 single nucleotide
polymorphisms (SNPs) from 10 adipose tissue associated genes (FTO,
LEP, LEPR, ADIPOQ, RETN, NAMPT, SERPINA12, ITLN, RARRES2 and
APLN) and their association with OA.
Methods: Bilateral hand radiographs of 542 occupationally active Fin-
nish female dentists and teachers aged 45-63 years were examined and
classiﬁed for the presence of OA by using reference images. The geno-
types were determined by PCR-based methods. Data regarding ﬁnger
joint pain and other risk factors were collected by a questionnaire.
Associations between the SNPs and hand OA were studied by IBM SPSS
statistical package Version 20 using principle component analysis based
genetic weighted scores and logistic regression.
Results: Association of studied SNPs to hand OA phenotypes were
found from LEPR, RARRES2, RETN and APLN genes. FTO and INTL SNPs
had borderline signiﬁcant associations to hand OA phenotypes. Princi-
ple component analysis resulted in 11 principle components weighted
by their genetic scores. Component 4 including four ADIPOQ SNPs,
component 6 including RARRES2 SNP, and component 8 including APLN
SNP had association to hand OA phenotypes.
Conclusions: Our results suggest that ADIPOQ, LEPR, RARRES2, RETN
and APLN genes may play role in hand OA etiology in Finnish women.
425
THE OSTEOARTHRITIS ASSOCIATION MARKED BY SNP rs6094710
MEDIATES ITS EFFECT BY REDUCING THE EXPRESSION OF NCOA3
IN JOINT TISSUES
M.D. Rushton, F.H. Gee, L.N. Reynard, J. Loughlin. Newcastle Univ.,
Newcastle upon Tyne, United Kingdom
Purpose: Recently it has been reported that the rare single nucleotide
polymorphism (SNP) rs6094710 is associated with hip osteoarthritis
(OA) in European populations. The SNP is a G/A transition, with the A-
allele having a frequency of 4%. The A-allele is more common in OA
cases versus controls and this association reached genome-wide sig-
niﬁcance, with a p-value of 7.9  109 and odds ratio of 1.28. rs6094710
is intergenic, maps to chromosome 20q12 and is located upstream of
the gene NCOA3, which codes for nuclear receptor co-activator 3. This
protein interacts with nuclear hormone receptors and has histone
acetyltransferase activity. Prior to the genetic study there were noreports of this protein having a role in OA. rs6094710 is in perfect
linkage disequilibrium with rs6094752, a missense polymorphism
leading to an amino acid change at position 218 of the NCOA3 protein.
However, scrutiny of a variety of public databases reveals that this
substitution is benign. This, combined with the absence of other pro-
tein-coding changes, make it probable that the 20q12 association
mediates its affect bymodulating gene expression. The aim of this study
therefore was to investigate the effect of genotype at rs6094710 on the
expression of NCOA3.
Methods: DNA and RNA were extracted from the cartilage of OA
patients who had undergone elective joint replacement surgery. DNA
was used to genotype patients at rs6094710. cDNA was synthesized
from the RNA. Using real-time quantitative PCR (qPCR) we initially
assessed whether genotype at rs6094710 correlated with overall
expression of NCOA3. We next assessed allelic expression imbalance
(AEI) of NCOA3, using the transcript SNP rs6094752 as a perfect proxy
for rs6094710. AEI was measured in heterozygotes by pyrosequencing,
with DNA providing the 1:1 ratio to which the cDNA ratios were com-
pared. We have previously generated gene expression microarray data
for hip cartilage from patients who had undergone joint replacement
surgery due to either OA (n¼ 11) or a neck-of-femur (NOF) fracture (n¼
13). This latter cartilage serves as a non-OA control. We used this data to
compare the expression of NCOA3 between OA and non-OA hip
cartilage.
Results: We performed qPCR analysis on the cartilage cDNA of 47 OA
patients and observed that overall NCOA3 expression correlated with
genotype at rs6094710 (p ¼ 0.021; t-test). Reduced expression of
NCOA3 was observed in individuals carrying a copy of the OA associated
A-allele. AEI analysis conﬁrmed the reduced expression from this allele,
which produced an average of 37% less transcript than the G allele (p <
0.001; t-test). This AEI was also observed in fat pad (also an average 37%
reduction) and synovial membrane (51% reduction) from OA patients,
and in both males and females. Analysis of our microarray data revealed
that NCOA3 is up-regulated 1.27 fold (p¼ 0.004; Mann–Whitney U test)
in OA hip cartilage relative to control NOF cartilage.
Conclusions: Our results indicate that the OA association signal marked
by rs6094710 is mediating its effect through a reduced expression of the
gene NCOA3. Based on our microarray data we hypothesize that NCOA3
expression needs to increase to attenuate the OA disease process but
that this increase is hampered in individuals carrying the A-allele of
rs6094710, which therefore acts as an OA risk allele. Much more
detailed functional studies of the gene and its encoded protein are now
merited.
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KNEE OSTEOARTHRITIS GENETICS IN FINNISH HEALTH 2000 SURVEY
M. Welling y, S. H€am€al€ainen z, A. Ojaj€arvi z, A. Hirvonen z,
M. Heli€ovaara x, P. Leino-Arjas z, M. M€annikk€o y, J. Karppinen k,z. y Inst. of
Hlth.Sci., Univ. of Oulu, Oulu, Finland; z Finnish Inst. of Occupational Hlth.,
Helsinki, Finland; xNatl. Inst. of Occupational Hlth., Helsinki, Finland;
kDept. of Physical and Rehabilitation Med., Oulu, Finland
Purpose: The aim of the study was to elucidate the genetic back-
ground of osteoarthritis (OA) and its correspondence to the genetics
of overweight and metabolic syndrome (MetS) in Finnish population.
OA and MetS share age and obesity as risk factors, and they both
have been considered as an inﬂammatory disease in which different
inﬂammatory mediators (for example cytokines, lipid derivatives,
reactive oxygen species) are released by cartilage, bone and syno-
vium. Obese patients with MetS have higher risk of developing OA
than obese patients without MetS. Investigators are now assessing
how MetS as a whole is linked to OA, and some have already
nominated ‘metabolic OA’ as the ﬁfth component of MetS. Genome-
wide association studies (GWAS) have identiﬁed several single
nucleotide polymorphisms (SNPs) associated with obesity and MetS.
One of the most investigated genes has been FTO (fat mass- and
obesity-associated) that regulates appetite. Genome-wide association
studies have identiﬁed that polymorphisms in the FTO gene are
associated also with risk of OA.
Methods: We chose to analyze 58 SNPs from 45 genes and their asso-
ciation to knee OA in Finnish Health 2000 Survey material. The Health
2000 Survey was conducted in Finland between fall 2000 and spring
2001. It is a representative sample of the Finnish population (n ¼ 8028).
The subjects were aged between 30 and 99. Knee osteoarthritis was
diagnosed in 6.1 % of men and 8.3 % of women. For the genetic analyses
